Greg Lazar Founder of Dualitas Therapeutics Backed byVersant VenturesBarbara Lubash LinkedIn SourcesDualitas Launches With $65 Million Series A to Advance Novel Bispecific Antibody Pipeline in Immune and Inflammatory Disease — 2025-09 Browse all founders · Browse investors
